Oligonucleotides are short sequences of nucleotides, typically made up of 20 to 25 bases. These synthetic molecules can be designed to bind to specific sequences of mRNA or DNA, thereby modulating gene expression. Their unique ability to target specific genes makes them a promising tool for cancer therapy.